68083-460-25 |
68083-460 |
HUMAN PRESCRIPTION DRUG |
Fosphenytoin sodium |
Fosphenytoin sodium |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS |
20231013 |
N/A |
ANDA |
ANDA214926 |
Gland Pharma Limited |
FOSPHENYTOIN SODIUM |
50 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (68083-460-25) / 2 mL in 1 VIAL, SINGLE-DOSE (68083-460-01) |
68083-461-10 |
68083-461 |
HUMAN PRESCRIPTION DRUG |
Fosphenytoin sodium |
Fosphenytoin sodium |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS |
20231013 |
N/A |
ANDA |
ANDA214926 |
Gland Pharma Limited |
FOSPHENYTOIN SODIUM |
50 mg/mL |
10 VIAL, SINGLE-DOSE in 1 CARTON (68083-461-10) / 10 mL in 1 VIAL, SINGLE-DOSE (68083-461-01) |
68462-622-10 |
68462-622 |
HUMAN PRESCRIPTION DRUG |
Fosphenytoin sodium |
Fosphenytoin sodium |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS |
20231013 |
N/A |
ANDA |
ANDA214926 |
GLENMARK PHARMACEUTICALS INC., USA |
FOSPHENYTOIN SODIUM |
50 mg/mL |
10 VIAL, SINGLE-DOSE in 1 CARTON (68462-622-10) / 10 mL in 1 VIAL, SINGLE-DOSE (68462-622-64) |
68462-621-02 |
68462-621 |
HUMAN PRESCRIPTION DRUG |
Fosphenytoin sodium |
Fosphenytoin sodium |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS |
20231013 |
N/A |
ANDA |
ANDA214926 |
GLENMARK PHARMACEUTICALS INC., USA |
FOSPHENYTOIN SODIUM |
50 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (68462-621-02) / 2 mL in 1 VIAL, SINGLE-DOSE (68462-621-54) |